Long Acting Moxifloxacin
Moxifloxacin is a new 8-methoxy-quinolone with a broad spectrum of antibacterial activity against organisms Gram-positive and Gram-negative bacteria, anaerobes, and atypical organism such as Mycoplasma and Chlamydia spp. It has some characteristics such as a wide spectrum of bactericidal activity, a large volume of distribution, low plasma protein binding, and relatively low Minimal Inhibitory Concentrations (MICs) against susceptible target microorganisms. It has the highest potency in its class against Staphylococcus aureus and Staphylococcus epidermidis. All these characteristics have made the moxifloxacin a drug of choice to treat many infectious diseases which could not be treated with older fluoroquinolones and other antimicrobials.
Truemox LA, the long acting moxifloxacin administration provides effective therapeutic concentration for up to 72 hours after single-dose administration.
CARRIERS (L-arginine, N-butyl alcohol, and benzyl alcohol) â q.s.
Intrvenous (iv) ROUTE preferably at jugular vein at the rate of 7.5 mg/kg of body weight.
Not safe for pregnant & young animals. Dont give with concomitant NSAID administration. Moxifloxacin is contraindicated in animals with a history of hypersensitivity to moxifloxacin, any member of the quinolone class of antimicrobial agents, or any of the product components.
30 & 100 ML.